Follow the 에스바이오메딕스 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 에스바이오메딕스 has recorded 28 insider filings. Market capitalisation: €216.7bn. The latest transaction was reported on 16 March 2026 (Other). Among the most active insiders: KANG SAEIL. Every trade is openly available.
28
Insider Decl.
n/a
Thresholds
n/a
10 ops.
Buy Volume
n/a
13 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,353 of 29,062 companies
24.8
score / 100
Value
25
Quality
25
FCF yld-3.9%
Earn yld-3.7%
EV/EBITDA·
ROE-41%
Gross mgn46%
Net mgn-49%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Cotizada en el mercado XKRX, 에스바이오메딕스 es una empresa centrada en el sector de la salud y farmacéutico. Se especializa en el desarrollo de soluciones innovadoras para el campo médico.